Michel, Martin C <br/><br/>
β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project.  [electronic resource] 

 -  Pharmacology & therapeutics  Mar 2016 
 - 66-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-016X 
<br/><br/><label>Standard No.: </label>10.1016/j.pharmthera.2016.01.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-3 Receptor Agonists--pharmacology<br/>Adrenergic beta-3 Receptor Antagonists--pharmacology<br/>Animals<br/>Antibodies--pharmacology<br/>Drug Repositioning<br/>Humans<br/>Ligands<br/>Receptors, Adrenergic, beta-3--genetics<br/>Syndrome<br/>Translational Research, Biomedical<br/>Urinary Bladder--physiology<br/>Urinary Bladder, Overactive--drug therapy